http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1061687-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
filingDate 1965-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1967-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1061687-A
titleOfInvention 3-amino-5-androstene compounds
abstract The invention comprises steroids of the formula <FORM:1061687/C2/1> (wherein R is hydrogen, A or A.CO and R1 and R11 are hydrogen or A, A being C1- 7 alkyl) and the preparation of the 3b -amino-17b -carbalkoxyandrost-5-enes by reacting a 6b -alkoxy-17b -carbalkoxy-3a ,5a -cycloandrostane with hydrazoic acid in a non-polar, inert, anhydrous, organic solvent and in the presence of an acid catalyst, separating the formed 3b -azido-17b -carbalkoxyandrost-5-ene and reducing this. The products can be acylated or alkylated at the amino group and hydrolysed to 17b -carboxy-compounds which can be re-esterified. Examples are given. 6b - Methoxy - 17b - carbomethoxy - 3a ,5a - cycloandrostane is prepared by refluxing 3b -p-toluenesulphonyloxy - 17b - carbomethoxy - androst-5-ene with sodium acetate and methanol.
priorityDate 1964-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421914963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454397067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86653488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430963959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88526976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69116228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238

Total number of triples: 28.